The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Phase 2 study to assess the efficacy, safety, and tolerability of the GDF-15 inhibitor ponsegromab in patients with cancer cachexia.

Jeffrey  Crawford

Honoraria - Actimed Therapeutics; AVEO; BioAtla; Enzychem Lifesciences; Faraday Pharmaceuticals; G1 Therapeutics; Merck; Partner Therapeutics; Pfizer; Sandoz; Seagen

Consulting or Advisory Role - Actimed Therapeutics; AVEO; BioAtla; Enzychem Lifesciences; Faraday Pharmaceuticals; G1 Therapeutics; Merck; Partner Therapeutics; Pfizer; Sandoz; Seagen

Research Funding - AstraZeneca (Inst); Helsinn Healthcare (Inst); Pfizer (Inst)

Shannon L  Lubaczewski

Employment - Pfizer

Stock and Other Ownership Interests  - Pfizer

Anil  Tarachandani

Employment - Pfizer

Stock and Other Ownership Interests  - Pfizer

Magdalena A  Harrington

Employment - Pfizer

Stock and Other Ownership Interests  - Pfizer

Yan  Weng

Employment - Pfizer

Stock and Other Ownership Interests  - Pfizer

Ruolun  Qiu

Employment - Pfizer

Stock and Other Ownership Interests  - Pfizer

Susie M  Collins

Employment - Pfizer

Stock and Other Ownership Interests  - Pfizer

Michelle I  Rossulek

Employment - Pfizer

Stock and Other Ownership Interests  - Pfizer

James H  Revkin

Employment - Pfizer

Leadership - Pfizer

Stock and Other Ownership Interests  - Pfizer